Search company, investor...

Predict your next investment

Venture Capital
cavendishimpactcapital.com

Investments

6

About Cavendish Impact Capital

Cavendish Impact Capital operates in between Impact Venture Capital and Private Equity; supporting early-stage companies with science and technologies that have established proof-of-concept, are beyond initial proof-of-model, are typically poised for significant value inflection within three years and that, given their success, will create meaningful impact locally and globally.

Headquarters Location

6098 West Lake Road

Cooperstown, New York, 13326,

United States

Want to inform investors similar to Cavendish Impact Capital about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Cavendish Impact Capital News

Turner Imaging Systems Closes Seed Funding Round

Feb 27, 2018

Turner Imaging Systems , an Orem, Utah-based developer of the Smart-C battery-powered mini C-arm, closed a seed funding round of undisclosed amount. The round was completed by Radnet Management, Inc., the principal operating subsidiary of RadNet, Inc. (NASDAQ:RDNT), with participation from Cavendish Impact Capital and private investors. In conjunction with the funding, John V. Crues, III MD, Vice President and Medical Director of RadNet, joined Turner’s Board of Directors. The company intends to use the funds to finance operations, continue development efforts related to its innovative technology, and commercialization of the Smart-C Portable C-Arm upon regulatory approval from the US Food and Drug Administration. Led by Dr. D. Clark Turner, PhD, President & CEO, Turner Imaging Systems develops and markets X-ray imaging systems that give the user the ability to acquire X-ray images wherever and whenever they are needed. The company is a spin-out from Turner Innovations, a developer of novel medical technologies. FinSMEs

Cavendish Impact Capital Investments

6 Investments

Cavendish Impact Capital has made 6 investments. Their latest investment was in Massive Bio as part of their Series A - II on November 11, 2020.

CBI Logo

Cavendish Impact Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/3/2020

Series A - II

Massive Bio

$2.6M

Yes

12

8/22/2019

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

5/6/2019

Series A - III

Subscribe to see more

$99M

Subscribe to see more

10

2/27/2018

Seed VC - II

Subscribe to see more

Subscribe to see more

10

11/28/2017

Seed VC

Subscribe to see more

Subscribe to see more

10

Date

11/3/2020

8/22/2019

5/6/2019

2/27/2018

11/28/2017

Round

Series A - II

Seed VC

Series A - III

Seed VC - II

Seed VC

Company

Massive Bio

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$2.6M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

12

10

10

10

10

Cavendish Impact Capital Team

1 Team Member

Cavendish Impact Capital has 1 team member, including current Managing Director, John Evey.

Name

Work History

Title

Status

John Evey

Managing Director

Current

Name

John Evey

Work History

Title

Managing Director

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.